Why the study?
Ebstein's anomaly is a rare congenital heart defect with limited data on complex pediatric cases presenting with hemoptysis and sepsis.
Case Report (n=1)
This case report demonstrates that symptomatic treatment can be a viable individualized approach for complex congenital heart diseases like Ebstein's anomaly complicated by sepsis when surgery is not feasible.
No clinical data provided; leaves open whether symptomatic treatment is viable for inoperable Ebstein's anomaly with sepsis.
Ebstein's anomaly is a rare congenital heart condition, occurring in only 1 to 5 out of every 200,000 live births, accounting for less than 1% of all cases of congenital heart defects. This anomaly is characterized by the downward displacement of the septal leaflet of the tricuspid valve and the presence of an atrialized right ventricle. Our patient, an eleven-year-old girl, initially presented with symptoms such as chest pain, shortness of breath, and hemoptysis (blood vomiting). Upon examination, we identified moderate tricuspid valve regurgitation and observed an enlarged, globe-shaped heart, which led us to diagnose the child with Ebstein's anomaly. Additionally, the presence of Escherichia coli in her blood resulted in sepsis. Given the patient's overall condition, cardiovascular surgery was not considered, and she was instead provided with symptomatic treatment. This case report highlights the possibility of successful pediatric outcomes in complex congenital heart diseases, emphasizing the need for individualized surgical treatment plans.
No takes yet. Share an insight, caveat, or question.
Arora et al. (2024) conducted a case report in Ebstein's Anomaly with Hemoptysis and Sepsis (n=1).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: